Detalhe da pesquisa
1.
Longitudinal analysis of serum neurofilament light chain levels as marker for neuronal damage in hereditary transthyretin amyloidosis.
Amyloid
; 31(2): 132-141, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38477065
2.
Neurofilament light chain, a biomarker for polyneuropathy in systemic amyloidosis.
Amyloid
; 28(1): 50-55, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32883119
3.
A real-life cohort study of immunoglobulin light-chain (AL) amyloidosis patients ineligible for autologous stem cell transplantation due to severe cardiac involvement or advanced disease.
Amyloid
; 27(2): 119-127, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32052655
4.
AA amyloidosis in a father and daughter as complication of PSTPIP1-associated myeloid-related proteinemia inflammatory (PAMI) syndrome.
Amyloid
; 31(1): 82-84, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37870967
5.
How well does liver span as part of the consensus criteria for liver involvement in AL amyloidosis perform?
Amyloid
; 30(4): 437-439, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37318263